Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 413

The DOI matches its Crossref record.

Argon Laser Photocoagulation for Neovascular Maculopathy: Five-Year Results From Randomized Clinical Trials

·1991·Archives of Ophthalmology

Abstract

• With completion of follow-up of all patients enrolled in three randomized clinical trials of argon laser photocoagulation of extrafoveal choroidal neovascular membranes secondary to senile (age-related) macular degeneration, ocular histoplasmosis, or idiopathic causes, the Macular Photocoagulation Study Group has demonstrated that laser treatment of such lesions is beneficial in preventing or delaying large losses of visual acuity for at least 5 years. In eyes with senile (age-related) macular degeneration as the underlying cause, the relative risk of losing six or more lines of visual acuity from the baseline level among untreated eyes (n = 117) compared with laser-treated eyes (n = 119) was 1.5 from 6 months through 5 years after entry (P=.001). In addition, after 5 years, untreated eyes had lost a mean of 7.1 lines of visual acuity, while laser-treated eyes had lost 5.2 lines. Recurrent neovascularization had been observed in 54% of laser-treated eyes by the end of the 5-year follow-up period. Among eyes with ocular histoplasmosis, untreated eyes (n = 130) had 3.6 times the risk of laser-treated eyes (n = 132) of losing six or more lines of visual acuity (P<.0001). Also, untreated eyes had lost a mean of 4.4 lines of visual acuity after 5 years, compared with only 0.9 lines lost by laser-treated eyes. Among laser-treated eyes, recurrent neovascularization had been observed in 26% by 5 years after enrollment. When the extrafoveal lesion was due to idiopathic causes, the relative risk of losing six or more lines of visual acuity from the baseline level among untreated eyes (n = 34) compared with laser-treated eyes (n = 33) was 2.3 (P=.04). The mean number of lines of visual acuity lost from baseline to the 5-year examination was 4.4 among untreated eyes and 2.7 among laser-treated eyes. Recurrent neovascularization was observed in 34% of laser-treated eyes during 5 years of follow-up. Thus, observations throughout 5 years of follow-up underscore the earlier recommendations from the Macular Photocoagulation Study Group that eyes with well-defined extrafoveal choroidal neovascular membranes secondary to senile macular degeneration, ocular histoplasmosis, and idiopathic causes be treated with argon laser photocoagulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/archopht.1991.01080080069030

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 413

Metadata

Venue
Archives of Ophthalmology
Published
1991-08-01
Volume
109
Issue
8
Pages
1109
ISSN
0003-9950 (ISSN-L)
OpenAlex
W4253904110
Cited by
413
References
0
FWCI
7.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Argon Laser Photocoagulation for Neovascular Maculopathy: Five-Year Results From Randomized Clinical Trials. https://app.cochat.ai/papers/10.1001/archopht.1991.01080080069030
The paper
Argon Laser Photocoagulation for Neovascular Maculopathy: Five-Year Results From Randomized Clinical Trials. (1991). Archives of Ophthalmology. https://doi.org/10.1001/archopht.1991.01080080069030

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.